Objectives: This study aimed to investigate the effects of age on pelvic floor symptoms (PFSs) in nulliparous women.
P elvic floor disorders represent an important part of women's health care. They encompass abnormalities of pelvic organ prolapse (POP), bladder dysfunction, and bowel dysfunction. These disorders are estimated to affect millions of women worldwide. It has been estimated that 41% of women aged 50 to 79 years have some degree of POP 1, 2 ; furthermore, prolapse is the most common benign indication for hysterectomy in postmenopausal women in the United States, 3 leading to an estimated annual cost of more than $1 billion dollars. 4, 5 Urinary incontinence alone has an estimated annual cost of approximately $16 billion, 6 and up to 10% of women in the United States ultimately undergo surgery for pelvic floor disorders. 7, 8 Despite the high prevalence and financial burden of these disorders, they continue to be poorly understood. There have been few epidemiologic studies evaluating pelvic floor disorders; studies in community-based populations are scarce.
Epidemiologic studies have suggested parity as a major factor in the development of all types of pelvic floor disorders. Miedel et al 9 evaluated nonobstetric risk factors for symptomatic POP and suggested that age and parity were the dominating risk factors but that obesity, strain, and other lifestyle and environmental factors may be associated with POP. Postmenopausal status has also been studied about the degree of prolapse and symptoms of prolapse, but these studies have not been controlled for parity.
Although age is an established risk factor for the development of most pelvic floor disorders, 7Y11 its effect on symptom severity remains unclear. Age has not consistently been associated with deterioration in pelvic organ support, urethral support, or levator function. 7, 11 It has been suggested that older women experience more pelvic floor symptoms (PFSs), although this relationship is poorly understood. Because most studies evaluating symptoms of pelvic floor disorders have included parity as a major factor, there is limited information on the effect of age on PFSs in nulliparous patients. The aim of this study was to investigate the effects of age on PFSs in a communitybased cohort of nulliparous women.
MATERIALS AND METHODS
This was a planned subanalysis of a study investigating the effects of age on the levator ani muscles in nulliparous women. The primary study was designed to characterize the levator ani structures in nulliparous women using 3-dimensional endovaginal ultrasonography and to examine the effects of age on these structures (data not yet published). This study was conducted at the University of Oklahoma Health Sciences Center, and was funded through a grant obtained from the University of Oklahoma College of Medicine Alumni Association. Institutional review board approval was obtained before initiating this study. Informed consent was obtained from all participants.
Participants
Between July 2009 and September 2010, 80 communitydwelling nulliparous women aged 21 to 70 years were recruited through local advertisements. Women with a history of prior incontinence or prolapse surgery, reproductive tract anomalies, or prior pelvic radiation therapy were excluded from this study. Women who were unable to complete the written questionnaires were also excluded.
After obtaining informed consent, all participants had a clinic visit at which time a complete history was obtained. Variables of interest included age, menopausal status, and medical and surgical histories. A standardized examination was also performed and included height, weight, and pelvic floor support assessment using the POP quantification (POP-Q) system, and measurement of vaginal closure force (VCF). All POP-Q examinations were performed by one of 3 fellowshiptrained urogynecologists. Finally, at this visit, all participants completed validated questionnaires as described below.
Outcomes Measures
Levator ani muscle function was assessed with a vaginal speculum designed to isometrically measure forces on the anterior and posterior bills of the speculum as the muscle contracts to close the pelvic floor. This instrument has previously been validated as a measure of VCF with excellent test-retest reliability. 12 Using this speculum, measurements of VCF were taken at rest and at maximal force and used to calculate the augmented VCF. These values were then used to determine if levator ani function was related to PFSs.
Quality of life and PFSs were assessed using self-administered questionnaires, namely, the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12). As a measure of overall physical and emotional health, each participant also completed the Short-Form Health Survey (SF-12).
The scale and total scores from the PFDI-20 were generated, which included the urinary distress inventory 6, the colorectalanal distress inventory 8, and the POP distress inventory. Each scale was summed and totalled for a score of 0 to 100, with higher scores indicating greater symptom burden. A summary score for the PFDI-20 was calculated by summing each of the scale scores. The PFIQ-7 also has 3 scales (bladder, bowel, and vaginal symptom impact scales) that were scored from 0 (least impact) to 100 (greatest adverse impact). A summary score for the PFIQ-7 was calculated by summing each of the scale scores. The PISQ-12 was scored from 0 to 48, with lower scores indicating poor sexual satisfaction.
Statistical Analysis
Statistical analysis was performed using SAS v9.2 (SAS Institute Inc, Cary, NC). Pearson correlation coefficient (r) was used to correlate the relationship between age and symptom scores generated from the questionnaires. Goodness of fit was assessed using the coefficient of determination (r 2 ). Spearman rank correlation coefficient (r s ) was used to correlate the relationship between perception of general health and the summary scores on the PFDI-20, PFIQ-7, and PISQ-12. Student t test was used to compare continuous variables and W 2 was used to compare proportions. Logistic regression was performed to assess predictors associated with PFSs. A significance level of 0.05 was used for all statistical tests.
RESULTS
Eighty participants were enrolled in this study. The median (range) age of the participants was 47 (22Y70) years. The average body mass index [mean (SD)] was 28.3 (7.2) kg/m 2 . Most of the participants were white (81.25%). Demographic information is shown in Table 1 . Of the participants, 30% were described themselves as postmenopausal, and 10% were on hormone replacement therapy (HRT), with only 1 participant having evidence of vaginal atrophy on examination. Of the participants, 52.5% considered themselves healthy; of those who reported a Of the participants, 60% considered themselves to be in ''very good'' or ''excellent'' health as reported on the SF-12 questionnaire. Most of the participants did not feel that their physical or emotional problems affected their activities or ability to accomplish tasks ( Table 2 ). As seen in Figure 1 , the most common prolapse detected on POP-Q examination was stage I for the all compartments.
Age was associated with higher PFDI-20 subscale and summary scores, corresponding to more bothersome PFSs (Table 3 ). Age was also associated with lower PISQ-12 scores, corresponding to worsening sexual function with age (r = j0.41, r 2 = 0.15; P = 0.0012). We found no association between advancing age and PFIQ scores (P = 0.12). Participant's perception of their overall health was negatively correlated with the PFDI-20 summary scores (r s = j0.28, P = 0.01) and the PFIQ-7 summary scores (r s = j0.38, P = 0.001) but not with the PISQ scores (r s = 0.02, P = 0.89). Vaginal closure force measurements did not correlate with increasing age. Likewise, no VCF measurement was significantly correlated with any symptom score. Representative scatter plots are shown in Figures 2 and 3 .
When symptomatic patients were considered, unadjusted logistic regression showed age to be associated with increased odds of having PFSs (OR, 1.881; 95% CI, 1.216Y2.91). Thus, for each decade after age 20, the odds of reporting PFSs increased by 1.88 in our study population. Menopausal status was not associated with increased odds of reporting PFSs (OR, 3.05, 95% CI, 0.80Y11.62). When age and age by menopause were incorporated into the model, age remained a predictor of reporting PFSs (OR, 1.78; 95% CI, 1.13Y2.78).
DISCUSSION
Pelvic floor disorders are common in women 13 and PFSs are usually assessed in the context of women seeking care for these disorders. Parity is considered one of the strongest risk factors for the development of pelvic floor disorders. The evidence for association of age in the absence of parity as a risk factor for pelvic floor disorders is scarce. This study demonstrates that advancing age is weakly associated with worsening PFSs and poorer sexual function in community-dwelling nulliparous women.
Condition-specific instruments for assessment of pelvic floor disorders are important tools to assess the impact of these disorders in women. Validated questionnaires such as the PFDI, PFIQ, and PISQ-12 are useful tools to help establish a baseline before an intervention, and to assess the overall impact of that intervention. Although preliminary normative data have been reported on a previous study, it is important to note that increasing age may impact ''baseline'' scores of PFSs. This is an important finding because age may be a determinant of higher symptom burden, independent of the intervention.
This study included a structured physical examination which included the objective measurement of vaginal strength. Most of our patients had stage I prolapse or less, allowing for the screening of symptoms in the absence of significant prolapse. Contrary to our expectations, we did not find a correlation between pelvic floor strength and increasing age in this group of nulliparous women. There is known to be significant atrophy of striated muscles in older patients 14 as well as increased collagen degradation in most tissues. 15 Trowbridge et al 11 demonstrated that pelvic organ support, urethral support, and levator function are not affected by increasing age. About 30% of our population described themselves as postmenopausal, although only 10% were on HRT. It remains unclear whether loss of muscle, a lack of estrogen, degradation of collagen, or other anatomic alterations are responsible for the increased incidence of PFSs in women of increasing age. Strengths of our study include the participation of communitydwelling nulliparous subjects, of a good continuum of ages. This study was able to demonstrate a weak correlation in nulliparous women between age and the presence of bothersome PFSs. Age was also associated with decreasing PISQ-12 score, indicating poorer sexual function. This is consistent with recent literature demonstrating that PFSs have been associated with poorer sexual function in women older than 40 years old. 16 One of the weaknesses of this analysis is that most of the participants were white women, but to draw race specific conclusions we would have required a much larger population. Multiple reports have suggested race as a significant factor in the development of pelvic floor disorders. 17 It is possible that our findings may have differed if we had studied a more ethnically diverse population. A potential weakness is the generalizability of our findings. These women were recruited through community advertising, and selection bias is always a possibility. Also, this study was limited to subjects who spoke fluent English and who could self-administer questionnaires.
Our study could not establish a causal association between increasing age and PFSs in nulliparous women. This study does highlight the potential for greater PFSs burden in nullipara due to increasing age. This an important point to consider for all physicians who care for older women. Further research will need to clarify whether this association is related to hormonal status and supplementation. Interventions to treat pelvic floor disorders will likely need a multifaceted approach to measure success in older women.
